Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

An Automated Multiparametric MRI Quantitative Imaging Prostate Habitat Risk Scoring System for Defining External Beam Radiotherapy Boost Volumes.

Stoyanova R, Chinea F, Kwon D, Reis IM, Tschudi Y, Parra NA, Breto AL, Padgett KR, Pra AD, Abramowitz MC, Kryvenko ON, Punnen S, Pollack A.

Int J Radiat Oncol Biol Phys. 2018 Jun 13. pii: S0360-3016(18)30937-4. doi: 10.1016/j.ijrobp.2018.06.003. [Epub ahead of print]

PMID:
29908220
2.

In vitro acaricide and anticholinesterase activities of digitaria insularis (Poaceae) against Rhipicephalus (Boophilus) microplus.

Santos FO, Lima HG, de Souza Santa Rosa S, das Mercês NB, Serra TM, Uzeda RS, Reis IMA, Botura MB, Branco A, Batatinha MJM.

Vet Parasitol. 2018 May 15;255:102-106. doi: 10.1016/j.vetpar.2018.04.003. Epub 2018 Apr 9.

PMID:
29773129
3.

Epidemiology, clinical features, and outcome of HTLV-1-related ATLL in an area of prevalence in the United States.

Malpica L, Pimentel A, Reis IM, Gotuzzo E, Lekakis L, Komanduri K, Harrington T, Barber GN, Ramos JC.

Blood Adv. 2018 Mar 27;2(6):607-620. doi: 10.1182/bloodadvances.2017011106.

4.

In vitro anthelmintic and cytotoxic activities of extracts of Persea willdenovii Kosterm (Lauraceae).

Rosa SSS, Santos FO, Lima HG, Reis IMA, Cassiano DSA, Vieira IJC, Braz-Filho R, Uzeda RS, Botura MB, Branco A, Batatinha MJM.

J Helminthol. 2017 Oct 25:1-7. doi: 10.1017/S0022149X17000979. [Epub ahead of print]

PMID:
29067895
5.

In vitro anthelmintic and cytotoxicity activities the Digitaria insularis (Poaceae).

Santos FO, de Lima HG, de Souza Santos NS, Serra TM, Uzeda RS, Reis IMA, Botura MB, Branco A, Batatinha MJM.

Vet Parasitol. 2017 Oct 15;245:48-54. doi: 10.1016/j.vetpar.2017.08.007. Epub 2017 Aug 16.

PMID:
28969837
6.

Presentation, Treatment, and Outcomes of Haitian Women With Breast Cancer in Miami and Haiti: Disparities in Breast Cancer-A Retrospective Cohort Study.

Gomez A, DeGennaro V, George SHL, Reis IM, Santamaria E, Westin GF, Gabriel D, Hurley J.

J Glob Oncol. 2016 Nov 2;3(4):389-399. doi: 10.1200/JGO.2016.005975. eCollection 2017 Aug.

7.

Prospective Pilot Study Comparing the Need for Adaptive Radiotherapy in Unresected Bulky Disease and in Postoperative Patients With Head and Neck Cancer.

Mahmoud O, Reis IM, Samuels MM, Elsayyad N, Bossart E, Both J, ELGhoneimy E, Moustafa M, AbdAllah M, Takita C.

Technol Cancer Res Treat. 2017 Jan 1:1533034617717624. doi: 10.1177/1533034617717624. [Epub ahead of print]

8.

Immunohistochemistry Analysis of CD44, EGFR, and p16 in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.

Cohen ER, Reis IM, Gomez C, Pereira L, Freiser ME, Hoosien G, Franzmann EJ.

Otolaryngol Head Neck Surg. 2017 Aug;157(2):239-251. doi: 10.1177/0194599817700371. Epub 2017 Apr 11.

PMID:
28397583
9.

Thiol oxidation of hemolymph proteins in oysters Crassostrea brasiliana as markers of oxidative damage induced by urban sewage exposure.

Trevisan R, Flores-Nunes F, Dolores ES, Mattos JJ, Piazza CE, Sasaki ST, Taniguchi S, Montone RC, Bícego MC, Dos Reis IMM, Zacchi FL, Othero BNM, Bastolla CLV, Mello DF, Fraga APM, Wendt N, Toledo-Silva G, Razzera G, Dafre AL, de Melo CMR, Bianchini A, Marques MRF, Bainy ACD.

Environ Toxicol Chem. 2017 Jul;36(7):1833-1845. doi: 10.1002/etc.3543. Epub 2016 Aug 12.

PMID:
27363828
10.

Effect of actionable somatic mutations on racial/ethnic disparities in head and neck cancer prognosis.

Wu ES, Park JY, Zeitouni JA, Gomez CR, Reis IM, Zhao W, Kwon D, Lee E, Nelson OL, Lin HY, Franzmann EJ, Savell J, McCaffrey TV, Goodwin WJ, Hu JJ.

Head Neck. 2016 Aug;38(8):1234-41. doi: 10.1002/hed.24420. Epub 2016 Mar 29.

PMID:
27028310
11.

Risk Stratification System for Oral Cancer Screening.

Pereira LH, Reis IM, Reategui EP, Gordon C, Saint-Victor S, Duncan R, Gomez C, Bayers S, Fisher P, Perez A, Goodwin WJ, Hu JJ, Franzmann EJ.

Cancer Prev Res (Phila). 2016 Jun;9(6):445-55. doi: 10.1158/1940-6207.CAPR-15-0200. Epub 2016 Mar 28.

12.

Prognostic impact of clinical tumor size on overall survival for subclassifying stages I and II vaginal cancer: A SEER analysis.

Wolfson AH, Reis IM, Portelance L, Diaz DA, Zhao W, Gibb RK.

Gynecol Oncol. 2016 May;141(2):255-259. doi: 10.1016/j.ygyno.2016.03.009. Epub 2016 Mar 22.

PMID:
26970567
13.

HER2 FISH classification of equivocal HER2 IHC breast cancers with use of the 2013 ASCO/CAP practice guideline.

Fan YS, Casas CE, Peng J, Watkins M, Fan L, Chapman J, Ikpatt OF, Gomez C, Zhao W, Reis IM.

Breast Cancer Res Treat. 2016 Feb;155(3):457-62. doi: 10.1007/s10549-016-3717-z. Epub 2016 Feb 19.

PMID:
26895325
14.

Characterization of risk factors for adjuvant radiotherapy-associated pain in a tri-racial/ethnic breast cancer population.

Lee E, Takita C, Wright JL, Reis IM, Zhao W, Nelson OL, Hu JJ.

Pain. 2016 May;157(5):1122-31. doi: 10.1097/j.pain.0000000000000489.

15.

Prospective evaluation of radiation-induced skin toxicity in a race/ethnically diverse breast cancer population.

Wright JL, Takita C, Reis IM, Zhao W, Lee E, Nelson OL, Hu JJ.

Cancer Med. 2016 Mar;5(3):454-64. doi: 10.1002/cam4.608. Epub 2016 Jan 14.

16.

Histological responses and localization of the cytochrome P450 (CYP2AU1) in Crassostrea brasiliana exposed to phenanthrene.

dos Reis IM, Mattos JJ, Garcez RC, Zacchi FL, Miguelão T, Flores-Nunes F, Toledo-Silva G, Sasaki ST, Taniguchi S, Bícego MC, Cargnin-Ferreira E, Bainy AC.

Aquat Toxicol. 2015 Dec;169:79-89. doi: 10.1016/j.aquatox.2015.10.011. Epub 2015 Oct 24.

PMID:
26519834
17.

Simulation-based estimation of mean and standard deviation for meta-analysis via Approximate Bayesian Computation (ABC).

Kwon D, Reis IM.

BMC Med Res Methodol. 2015 Aug 12;15:61. doi: 10.1186/s12874-015-0055-5.

18.

Serum GADD45a methylation is a useful biomarker to distinguish benign vs malignant prostate disease.

Reis IM, Ramachandran K, Speer C, Gordian E, Singal R.

Br J Cancer. 2015 Jul 28;113(3):460-8. doi: 10.1038/bjc.2015.240. Epub 2015 Jul 14.

19.

Long-term response to renal ischaemia in the human kidney after partial nephrectomy: results from a prospective clinical trial.

Kallingal GJ, Weinberg JM, Reis IM, Nehra A, Venkatachalam MA, Parekh DJ.

BJU Int. 2016 May;117(5):766-74. doi: 10.1111/bju.13192. Epub 2015 Jul 18.

20.

Locoregional and Overall Recurrence After Neaodjuvant Endocrine Therapy Versus Chemotherapy in Postmenopausal Women With Estrogen Receptor+ HER2- Breast Cancer.

Wright JL, Saigal K, Reis IM, Zhao W, Takita C, Ambros T, Saeed AM, Sujoy V, Hurley J.

Am J Clin Oncol. 2017 Oct;40(5):490-497. doi: 10.1097/COC.0000000000000194.

PMID:
26017482
21.

Head and neck second primary cancer rates in the human papillomavirus era: A population-based analysis.

Diaz DA, Reis IM, Weed DT, Elsayyad N, Samuels M, Abramowitz MC.

Head Neck. 2016 Apr;38 Suppl 1:E873-83. doi: 10.1002/hed.24119. Epub 2015 Aug 6.

PMID:
25966421
22.

Neoadjuvant Radiotherapy Improves Survival in Patients With T2b/T3 Bladder Cancer: A Population-Based Analysis.

Diaz DA, Pollack A, Reis IM, Mahmoud O, Gonzalgo ML, Ishkanian A, Fernandez G, Manoharan M, Abramowitz MC.

Clin Genitourin Cancer. 2015 Aug;13(4):378-384.e1. doi: 10.1016/j.clgc.2015.02.014. Epub 2015 Mar 5.

PMID:
25907230
23.

Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.

Weed DT, Vella JL, Reis IM, De la Fuente AC, Gomez C, Sargi Z, Nazarian R, Califano J, Borrello I, Serafini P.

Clin Cancer Res. 2015 Jan 1;21(1):39-48. doi: 10.1158/1078-0432.CCR-14-1711. Epub 2014 Oct 15.

24.

Racial variations in radiation-induced skin toxicity severity: data from a prospective cohort receiving postmastectomy radiation.

Wright JL, Takita C, Reis IM, Zhao W, Lee E, Hu JJ.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):335-43. doi: 10.1016/j.ijrobp.2014.06.042.

PMID:
25304794
25.

Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy.

Singal R, Ramachandran K, Gordian E, Quintero C, Zhao W, Reis IM.

Clin Genitourin Cancer. 2015 Feb;13(1):22-31. doi: 10.1016/j.clgc.2014.07.008. Epub 2014 Aug 1.

PMID:
25178642
26.

Inflammatory biomarker C-reactive protein and radiotherapy-induced early adverse skin reactions in patients with breast cancer.

Rodriguez-Gil JL, Takita C, Wright J, Reis IM, Zhao W, Lally BE, Hu JJ.

Cancer Epidemiol Biomarkers Prev. 2014 Sep;23(9):1873-83. doi: 10.1158/1055-9965.EPI-14-0263. Epub 2014 Jun 10.

27.

Free circulating DNA as a biomarker of prostate cancer: comparison of quantitation methods.

Ramachandran K, Speer CG, Fiddy S, Reis IM, Singal R.

Anticancer Res. 2013 Oct;33(10):4521-9.

PMID:
24123025
28.

Risk factors for locoregional failure in patients with inflammatory breast cancer treated with trimodality therapy.

Saigal K, Hurley J, Takita C, Reis IM, Zhao W, Rodgers SE, Wright JL.

Clin Breast Cancer. 2013 Oct;13(5):335-43. doi: 10.1016/j.clbc.2013.04.002. Epub 2013 Jul 10.

PMID:
23850216
29.

Predictors of locoregional outcome in HER2-overexpressing breast cancer treated with neoadjuvant chemotherapy.

Arsenault D, Hurley J, Takita C, Reis IM, Zhao W, Rodgers S, Wright JL.

Am J Clin Oncol. 2015 Aug;38(4):348-52. doi: 10.1097/COC.0b013e31829d1eb8.

PMID:
23799288
30.

Impact of surgery-radiation interval on locoregional outcome in patients receiving neo-adjuvant therapy and mastectomy.

Desai S, Hurley J, Takita C, Reis IM, Zhao W, Rodgers SE, Wright JL.

Breast J. 2013 Jul-Aug;19(4):427-30. doi: 10.1111/tbj.12140. Epub 2013 Jun 11.

PMID:
23750652
31.

The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients.

Hurley J, Reis IM, Rodgers SE, Gomez-Fernandez C, Wright J, Leone JP, Larrieu R, Pegram MD.

Breast Cancer Res Treat. 2013 Apr;138(3):783-94. doi: 10.1007/s10549-013-2497-y. Epub 2013 Mar 31.

PMID:
23542956
32.

Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo.

Simpkins F, Hevia-Paez P, Sun J, Ullmer W, Gilbert CA, da Silva T, Pedram A, Levin ER, Reis IM, Rabinovich B, Azzam D, Xu XX, Ince TA, Yang JY, Verhaak RG, Lu Y, Mills GB, Slingerland JM.

Clin Cancer Res. 2012 Nov 1;18(21):5911-23. doi: 10.1158/1078-0432.CCR-12-1257. Epub 2012 Aug 15.

33.

Low biopsy volume in ureteroscopy does not affect tumor biopsy grading in upper tract urothelial carcinoma.

Rojas CP, Castle SM, Llanos CA, Santos Cortes JA, Bird V, Rodriguez S, Reis IM, Zhao W, Gomez-Fernandez C, Leveillee RJ, Jorda M.

Urol Oncol. 2013 Nov;31(8):1696-700. doi: 10.1016/j.urolonc.2012.05.010. Epub 2012 Jul 21.

PMID:
22819696
34.

Predictors of locoregional outcome in patients receiving neoadjuvant therapy and postmastectomy radiation.

Wright JL, Takita C, Reis IM, Zhao W, Saigal K, Wolfson A, Markoe A, Moller M, Hurley J.

Cancer. 2013 Jan 1;119(1):16-25. doi: 10.1002/cncr.27717. Epub 2012 Jun 26.

35.

Mucosal melanomas of the head and neck: the role of postoperative radiation therapy.

Saigal K, Weed DT, Reis IM, Markoe AM, Wolfson AH, Nguyen-Sperry J.

ISRN Oncol. 2012;2012:785131. doi: 10.5402/2012/785131. Epub 2012 Apr 11.

36.

CD10+ and CK7/RON- immunophenotype distinguishes renal cell carcinoma, conventional type with eosinophilic morphology from its mimickers.

Yasir S, Herrera L, Gomez-Fernandez C, Reis IM, Umar S, Leveillee R, Kava B, Jorda M.

Appl Immunohistochem Mol Morphol. 2012 Oct;20(5):454-61. doi: 10.1097/PAI.0b013e31823fecd3.

PMID:
22417859
37.

Racial disparity in estrogen receptor positive breast cancer patients receiving trimodality therapy.

Wright JL, Reis IM, Zhao W, Panoff JE, Takita C, Sujoy V, Gomez CR, Jorda M, Franceschi D, Hurley J.

Breast. 2012 Jun;21(3):276-83. doi: 10.1016/j.breast.2011.11.003. Epub 2011 Dec 16.

PMID:
22178596
38.

Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancer.

Han HS, Reis IM, Zhao W, Kuroi K, Toi M, Suzuki E, Syme R, Chow L, Yip AY, Glück S.

Eur J Cancer. 2011 Nov;47(17):2537-45. doi: 10.1016/j.ejca.2011.06.027. Epub 2011 Jul 7.

PMID:
21741825
39.

Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer.

Smith TR, Liu-Mares W, Van Emburgh BO, Levine EA, Allen GO, Hill JW, Reis IM, Kresty LA, Pegram MD, Miller MS, Hu JJ.

Carcinogenesis. 2011 Sep;32(9):1354-60. doi: 10.1093/carcin/bgr117. Epub 2011 Jun 23.

40.

Higher chest wall dose results in improved locoregional outcome in patients receiving postmastectomy radiation.

Panoff JE, Takita C, Hurley J, Reis IM, Zhao W, Rodgers SE, Gunaseelan V, Wright JL.

Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1192-9. doi: 10.1016/j.ijrobp.2011.02.045. Epub 2011 Apr 22.

PMID:
21514739
41.

Risk of locoregional recurrence by receptor status in breast cancer patients receiving modern systemic therapy and post-mastectomy radiation.

Panoff JE, Hurley J, Takita C, Reis IM, Zhao W, Sujoy V, Gomez CR, Jorda M, Koniaris L, Wright JL.

Breast Cancer Res Treat. 2011 Aug;128(3):899-906. doi: 10.1007/s10549-011-1495-1. Epub 2011 Apr 8.

PMID:
21475999
42.

Serum free circulating DNA is a useful biomarker to distinguish benign versus malignant prostate disease.

Gordian E, Ramachandran K, Reis IM, Manoharan M, Soloway MS, Singal R.

Cancer Epidemiol Biomarkers Prev. 2010 Aug;19(8):1984-91. doi: 10.1158/1055-9965.EPI-10-0287. Epub 2010 Jul 20.

43.

Chronic consumption of fructose rich soft drinks alters tissue lipids of rats.

Botezelli JD, Dalia RA, Reis IM, Barbieri RA, Rezende TM, Pelarigo JG, Codogno J, Gonçalves R, Mello MA.

Diabetol Metab Syndr. 2010 Jun 23;2:43. doi: 10.1186/1758-5996-2-43.

44.

Cognitive-behavioral therapy to promote smoking cessation among African American smokers: a randomized clinical trial.

Webb MS, de Ybarra DR, Baker EA, Reis IM, Carey MP.

J Consult Clin Psychol. 2010 Feb;78(1):24-33. doi: 10.1037/a0017669.

PMID:
20099947
45.

Surgeon-performed ultrasound can predict differentiated thyroid cancer in patients with solitary thyroid nodules.

Jabiev AA, Ikeda MH, Reis IM, Solorzano CC, Lew JI.

Ann Surg Oncol. 2009 Nov;16(11):3140-5. doi: 10.1245/s10434-009-0652-9. Epub 2009 Aug 5.

PMID:
19655201
46.

Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data.

Abdel-Wahab M, Reis IM, Wu J, Duncan R.

Urology. 2009 Oct;74(4):866-71. doi: 10.1016/j.urology.2009.02.085. Epub 2009 Jul 22.

PMID:
19628258
47.

Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target.

Ramachandran K, Gopisetty G, Gordian E, Navarro L, Hader C, Reis IM, Schulz WA, Singal R.

Cancer Res. 2009 Feb 15;69(4):1527-35. doi: 10.1158/0008-5472.CAN-08-3609. Epub 2009 Feb 3.

48.

Small cell carcinoma of the head and neck: the university of Miami experience.

Hatoum GF, Patton B, Takita C, Abdel-Wahab M, LaFave K, Weed D, Reis IM.

Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):477-81. doi: 10.1016/j.ijrobp.2008.08.014. Epub 2008 Nov 10.

PMID:
19004574
49.

Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy.

Abdel-Wahab M, Reis IM, Hamilton K.

Int J Radiat Oncol Biol Phys. 2008 Sep 1;72(1):58-68. doi: 10.1016/j.ijrobp.2007.12.043. Epub 2008 Apr 18.

PMID:
18374503
50.

IRF-4 and c-Rel expression in antiviral-resistant adult T-cell leukemia/lymphoma.

Ramos JC, Ruiz P Jr, Ratner L, Reis IM, Brites C, Pedroso C, Byrne GE Jr, Toomey NL, Andela V, Harhaj EW, Lossos IS, Harrington WJ Jr.

Blood. 2007 Apr 1;109(7):3060-8.

Supplemental Content

Support Center